Life's loss is Illumina's gain, as Ion Torrent founder leaves
This article was originally published in Clinica
Executive Summary
Jonathan Rothberg has resigned as CEO of Life Technologies’ subsidiary Ion Torrent, its next-generation DNA sequencing business, “to pursue other opportunities”. The move is “not a surprise given Dr Rothberg’s entrepreneurial background”, according to Goldman Sachs analyst Isaac Ro, who noted: “Since the announcement of the proposed [Thermo Fisher Scientific/Life] merger, investors have questioned what Dr Rothberg’s position might be in the combined company.” Thermo Fisher agreed to buy Life for $13.6 billion (excluding debt) in April (www.clinica.co.uk, 16 April 2013).